TheStreet’s Action Alerts PLUS Portfolio Manager Jim Cramer said Eli Lilly has been overpromising and underdelivering. ‘Lily has this held out Alzheimer’s franchise,’ Cramer said. ‘Alzheimer’s is the largest market for any drug and it seems completely intractable.’
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
